STOK R&D Expense Growth
Stoke Therapeutics Inc · R&D Expense Growth
STOK R&D Expense Growth
Latest reported54.74%period ending
STOK FY R&D Growth (YoY) (0.00% → 54.74%)
Latest values, visible window
High-resolution chart · PNG
STOK r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 54.7373% | |
| 8.3934% | |
| 5.6451% | |
| 43.6955% | |
| 68.2393% | |
| 38.1016% | |
| 178.5091% | |
| 132.657% | |
| 0% |